PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15663233-4	2004	RESULTS: Frequency distributions of CYP17 genotype were TC (51.1%), CC (33.8%), and TT (15.1%).	Technetium	56-58	cytochrome P450 family 17 subfamily A member 1	Homo sapiens	36-41	
31170334-8	2019	CONCLUSIONS: The rs1004467 and rs11191548 in the CYP17A1 gene are associated with a decreased risk of hypercholesterolemia and lower serum TC levels in Han Chinese.	Technetium	139-141	cytochrome P450 family 17 subfamily A member 1	Homo sapiens	49-56	
25208301-4	2015	RESULTS: The prevalence rates of CYP17A1 genotype TT, TC and CC were 49.69%, 43.71% and 6.6% in the case group and those were 44.77%, 46.08% and 9.15% in the control group.	Technetium	54-56	cytochrome P450 family 17 subfamily A member 1	Homo sapiens	33-40	
20133979-11	2010	The risk possesed by the TC varient of CYP19 was reduced when evaluated with A1, the protective allele of CYP17 (p=0.082).	Technetium	25-27	cytochrome P450 family 17 subfamily A member 1	Homo sapiens	106-111	
31966724-9	2017	Logistic regression analysis showed that SRD5A2 V89L and CYP17 -34T>C polymorphisms and CYP17 -34T>C (TC + CC)/SRD5A2 V89L (VV) combined genotypes were significantly related with the clinical progression of BHP.	Technetium	102-104	cytochrome P450 family 17 subfamily A member 1	Homo sapiens	88-93	
24389397-7	2014	RESULTS: Patients who are carriers of the Cyp17 genotype CC have less chance of developing TD compared to patients who are carriers of the Cyp17 genotypes TC or TT (p<0.05).	Technetium	155-157	cytochrome P450 family 17 subfamily A member 1	Homo sapiens	139-144